Sepsis Market Share, Size, Definition, Treatment, Causes, Pipeline Review, H1 2016

Sepsis Market Share, Size, Treatment, Symptoms, Causes,
Pipeline Review, H1 2016 by Radiant Insights
Global Markets Direct's, 'Sepsis - Pipeline Review, H2 2016', provides an overview of the Sepsis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Sepsis, complete with
analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for Sepsis and features dormant and discontinued
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources.
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis.
Read Complete Report with TOC @
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision
making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
- The report provides a snapshot of the global therapeutic landscape of Sepsis
- The report reviews pipeline therapeutics for Sepsis by companies and universities/research institutes based on
information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description,
descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Sepsis therapeutics and enlists all their major and minor projects
- The report assesses Sepsis therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Sepsis
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Sepsis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Sepsis pipeline depth and focus of Indication
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Buy a Sample Copy of This Report @
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Sepsis Overview 11
Therapeutics Development 12
Pipeline Products for Sepsis - Overview 12
Pipeline Products for Sepsis - Comparative Analysis 13
Sepsis - Therapeutics under Development by Companies 14
Sepsis - Therapeutics under Investigation by Universities/Institutes 19
Sepsis - Pipeline Products Glance 21
Late Stage Products 21
Clinical Stage Products 22
Early Stage Products 23
Unknown Stage Products 24
Sepsis - Products under Development by Companies 25
Sepsis - Products under Investigation by Universities/Institutes 30
Sepsis - Companies Involved in Therapeutics Development 31
Adrenomed AG 31
Altor BioScience Corporation 32
Am-Pharma B.V. 33
Arch Biopartners, Inc. 34
Aridis Pharmaceuticals LLC 35
Asahi Kasei Pharma Corp. 36
Astellas Pharma Inc. 37
Batu Biologics, Inc. 38
Biomedica Management Corporation 39
Boehringer Ingelheim GmbH 40
Read Complete Report with TOC @
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure market research reports, helping them
in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries
and a host of micro markets. In addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Visit our Blog: